Literature DB >> 27431689

Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg).

Chi Tung Choy1, Chi Hang Wong2, Herbert Ho Fung Loong3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27431689     DOI： 10.1007/s11060-016-2209-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  3 in total

1.  Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.

Authors:  Oula Khoury; Noura Ghazale; Everett Stone; Mirvat El-Sibai; Arthur E Frankel; Ralph J Abi-Habib
Journal:  J Neurooncol       Date:  2015-01-08       Impact factor: 4.130

2.  Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.

Authors:  Tomas Fiedler; Madlen Strauss; Silvio Hering; Ulrike Redanz; Doreen William; Yvonne Rosche; Carl Friedrich Classen; Bernd Kreikemeyer; Michael Linnebacher; Claudia Maletzki
Journal:  Cancer Biol Ther       Date:  2015-03-16       Impact factor: 4.742

3.  Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.

Authors:  T L Lam; G K Y Wong; H C Chong; P N M Cheng; S C Choi; T L Chow; S Y Kwok; R T P Poon; D N Wheatley; W H Lo; Y C Leung
Journal:  Cancer Lett       Date:  2009-01-12       Impact factor: 8.679
  3 in total
  1 in total

1.  Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth.

Authors:  Kefeng Wang; Yin Sun; Changcheng Guo; Tao Liu; Xiang Fei; Chawnshang Chang
Journal:  Cell Death Dis       Date:  2019-04-18       Impact factor: 8.469
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.